AmBisome: Marketed to treat fever of unknown origin

National Cancer Institute (Bethesda, Md.) researchers and colleagues published in The New England Journal of Medicine a 687-patient comparison of AmBisome

Read the full 211 word article

How to gain access

Continue reading with a
two-week free trial.